Navamedic ASA: Q1 2022 financial results

Publisert: 10.05.2022

Navamedic ASA acquires Impolin AB and bolsters its product portfolio

Publisert: 05.05.2022

Navamedic: Annual report 2021

Publisert: 29.04.2022

Navamedic ASA: Q4 2021 financial results

Publisert: 17.02.2022

Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea

Publisert: 16.02.2022

Navamedic ASA: Invitation to 2021 Fourth quarter presentation

Publisert: 14.02.2022